Toronto-based Mindset Pharma is set to be acquired by the U.S. arm of Otsuka Pharmaceutical in an all-cash transaction valued at around CAD $80m (around USD $60m). This is a breaking story. More to follow.

Source

Previous articleCOMPASS Pathways to participate in upcoming September investor conferences
Next articleFILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA